AAAAAA

   
Results: 1-2 |
Results: 2
HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS BLOOD OR MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA (NHL) AND HODGKINS-DISEASE (HD) AT RISK FOR PULMONARY COMPLICATIONS
Authors: SALZMAN D CARABASI MA BRIGGS AD GEILS GF VAUGHAN WP
Citation: D. Salzman et al., HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS BLOOD OR MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA (NHL) AND HODGKINS-DISEASE (HD) AT RISK FOR PULMONARY COMPLICATIONS, Blood, 86(10), 1995, pp. 3840-3840
RAPID PLATELET RECOVERY-TIME FOLLOWING HIGH-DOSE CHEMOTHERAPY (HDT) FOR METASTATIC BREAST-CANCER SUPPORTED BY HEMATOPOIETIC STEM-CELLS COLLECTED FROM BLOOD (BSC) AFTER G-CSF ADMINISTRATION
Authors: GEILS GF TILDEN AB CARABASI MH FRIEDBERG RC VAUGHAN WP
Citation: Gf. Geils et al., RAPID PLATELET RECOVERY-TIME FOLLOWING HIGH-DOSE CHEMOTHERAPY (HDT) FOR METASTATIC BREAST-CANCER SUPPORTED BY HEMATOPOIETIC STEM-CELLS COLLECTED FROM BLOOD (BSC) AFTER G-CSF ADMINISTRATION, Blood, 84(10), 1994, pp. 10000709-10000709
Risultati: 1-2 |